1 Antibody Drug Conjugate Market Overview 1.1 Antibody Drug Conjugate Product Scope 1.2 Antibody Drug Conjugate Segment by Type 1.2.1 Global Antibody Drug Conjugate Sales by Type (2016 & 2021 & 2027) 1.2.2 Adcetris 1.2.3 Kadcyl 1.2.4 Other 1.3 Antibody Drug Conjugate Segment by Application 1.3.1 Global Antibody Drug Conjugate Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Hospital 1.3.3 Pharmaceutical Company 1.3.4 Research Institutions 1.4 Antibody Drug Conjugate Market Estimates and Forecasts (2016-2027) 1.4.1 Global Antibody Drug Conjugate Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Antibody Drug Conjugate Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Antibody Drug Conjugate Price Trends (2016-2027) 2 Antibody Drug Conjugate Estimates and Forecasts by Region 2.1 Global Antibody Drug Conjugate Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Antibody Drug Conjugate Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Antibody Drug Conjugate Sales Market Share by Region (2016-2021) 2.2.2 Global Antibody Drug Conjugate Revenue Market Share by Region (2016-2021) 2.3 Global Antibody Drug Conjugate Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Antibody Drug Conjugate Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Antibody Drug Conjugate Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Antibody Drug Conjugate Estimates and Projections (2016-2027) 2.4.2 Europe Antibody Drug Conjugate Estimates and Projections (2016-2027) 2.4.3 China Antibody Drug Conjugate Estimates and Projections (2016-2027) 2.4.4 Japan Antibody Drug Conjugate Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Antibody Drug Conjugate Estimates and Projections (2016-2027) 2.4.6 India Antibody Drug Conjugate Estimates and Projections (2016-2027) 3 Global Antibody Drug Conjugate Competition Landscape by Players 3.1 Global Top Antibody Drug Conjugate Players by Sales (2016-2021) 3.2 Global Top Antibody Drug Conjugate Players by Revenue (2016-2021) 3.3 Global Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Drug Conjugate as of 2020) 3.4 Global Antibody Drug Conjugate Average Price by Company (2016-2021) 3.5 Manufacturers Antibody Drug Conjugate Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Antibody Drug Conjugate Market Size by Type 4.1 Global Antibody Drug Conjugate Historic Market Review by Type (2016-2021) 4.1.1 Global Antibody Drug Conjugate Sales Market Share by Type (2016-2021) 4.1.2 Global Antibody Drug Conjugate Revenue Market Share by Type (2016-2021) 4.1.3 Global Antibody Drug Conjugate Price by Type (2016-2021) 4.2 Global Antibody Drug Conjugate Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Antibody Drug Conjugate Sales Forecast by Type (2022-2027) 4.2.2 Global Antibody Drug Conjugate Revenue Forecast by Type (2022-2027) 4.2.3 Global Antibody Drug Conjugate Price Forecast by Type (2022-2027) 5 Global Antibody Drug Conjugate Market Size by Application 5.1 Global Antibody Drug Conjugate Historic Market Review by Application (2016-2021) 5.1.1 Global Antibody Drug Conjugate Sales Market Share by Application (2016-2021) 5.1.2 Global Antibody Drug Conjugate Revenue Market Share by Application (2016-2021) 5.1.3 Global Antibody Drug Conjugate Price by Application (2016-2021) 5.2 Global Antibody Drug Conjugate Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Antibody Drug Conjugate Sales Forecast by Application (2022-2027) 5.2.2 Global Antibody Drug Conjugate Revenue Forecast by Application (2022-2027) 5.2.3 Global Antibody Drug Conjugate Price Forecast by Application (2022-2027) 6 North America Antibody Drug Conjugate Market Facts & Figures 6.1 North America Antibody Drug Conjugate Sales by Company 6.1.1 North America Antibody Drug Conjugate Sales by Company (2016-2021) 6.1.2 North America Antibody Drug Conjugate Revenue by Company (2016-2021) 6.2 North America Antibody Drug Conjugate Sales Breakdown by Type 6.2.1 North America Antibody Drug Conjugate Sales Breakdown by Type (2016-2021) 6.2.2 North America Antibody Drug Conjugate Sales Breakdown by Type (2022-2027) 6.3 North America Antibody Drug Conjugate Sales Breakdown by Application 6.3.1 North America Antibody Drug Conjugate Sales Breakdown by Application (2016-2021) 6.3.2 North America Antibody Drug Conjugate Sales Breakdown by Application (2022-2027) 7 Europe Antibody Drug Conjugate Market Facts & Figures 7.1 Europe Antibody Drug Conjugate Sales by Company 7.1.1 Europe Antibody Drug Conjugate Sales by Company (2016-2021) 7.1.2 Europe Antibody Drug Conjugate Revenue by Company (2016-2021) 7.2 Europe Antibody Drug Conjugate Sales Breakdown by Type 7.2.1 Europe Antibody Drug Conjugate Sales Breakdown by Type (2016-2021) 7.2.2 Europe Antibody Drug Conjugate Sales Breakdown by Type (2022-2027) 7.3 Europe Antibody Drug Conjugate Sales Breakdown by Application 7.3.1 Europe 127 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 127 Sales Breakdown by Application (2022-2027) 8 China Antibody Drug Conjugate Market Facts & Figures 8.1 China Antibody Drug Conjugate Sales by Company 8.1.1 China Antibody Drug Conjugate Sales by Company (2016-2021) 8.1.2 China Antibody Drug Conjugate Revenue by Company (2016-2021) 8.2 China Antibody Drug Conjugate Sales Breakdown by Type 8.2.1 China Antibody Drug Conjugate Sales Breakdown by Type (2016-2021) 8.2.2 China Antibody Drug Conjugate Sales Breakdown by Type (2022-2027) 8.3 China Antibody Drug Conjugate Sales Breakdown by Application 8.3.1 China 158 Sales Breakdown by Application (2016-2021) 8.3.2 China 158 Sales Breakdown by Application (2022-2027) 9 Japan Antibody Drug Conjugate Market Facts & Figures 9.1 Japan Antibody Drug Conjugate Sales by Company 9.1.1 Japan Antibody Drug Conjugate Sales by Company (2016-2021) 9.1.2 Japan Antibody Drug Conjugate Revenue by Company (2016-2021) 9.2 Japan Antibody Drug Conjugate Sales Breakdown by Type 9.2.1 Japan Antibody Drug Conjugate Sales Breakdown by Type (2016-2021) 9.2.2 Japan Antibody Drug Conjugate Sales Breakdown by Type (2022-2027) 9.3 Japan Antibody Drug Conjugate Sales Breakdown by Application 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Antibody Drug Conjugate Market Facts & Figures 10.1 Southeast Asia Antibody Drug Conjugate Sales by Company 10.1.1 Southeast Asia Antibody Drug Conjugate Sales by Company (2016-2021) 10.1.2 Southeast Asia Antibody Drug Conjugate Revenue by Company (2016-2021) 10.2 Southeast Asia Antibody Drug Conjugate Sales Breakdown by Type 10.2.1 Southeast Asia Antibody Drug Conjugate Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Antibody Drug Conjugate Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Antibody Drug Conjugate Sales Breakdown by Application 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Antibody Drug Conjugate Market Facts & Figures 11.1 India Antibody Drug Conjugate Sales by Company 11.1.1 India Antibody Drug Conjugate Sales by Company (2016-2021) 11.1.2 India Antibody Drug Conjugate Revenue by Company (2016-2021) 11.2 India Antibody Drug Conjugate Sales Breakdown by Type 11.2.1 India Antibody Drug Conjugate Sales Breakdown by Type (2016-2021) 11.2.2 India Antibody Drug Conjugate Sales Breakdown by Type (2022-2027) 11.3 India Antibody Drug Conjugate Sales Breakdown by Application 11.3.1 India Antibody Drug Conjugate Sales Breakdown by Application (2016-2021) 11.3.2 India Antibody Drug Conjugate Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Antibody Drug Conjugate Business 12.1 Seattle Genetics/Takeda 12.1.1 Seattle Genetics/Takeda Corporation Information 12.1.2 Seattle Genetics/Takeda Business Overview 12.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Seattle Genetics/Takeda Antibody Drug Conjugate Products Offered 12.1.5 Seattle Genetics/Takeda Recent Development 12.2 Roche 12.2.1 Roche Corporation Information 12.2.2 Roche Business Overview 12.2.3 Roche Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Roche Antibody Drug Conjugate Products Offered 12.2.5 Roche Recent Development 12.3 ImmunoGen 12.3.1 ImmunoGen Corporation Information 12.3.2 ImmunoGen Business Overview 12.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.3.4 ImmunoGen Antibody Drug Conjugate Products Offered 12.3.5 ImmunoGen Recent Development 12.4 Immunomedics 12.4.1 Immunomedics Corporation Information 12.4.2 Immunomedics Business Overview 12.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Immunomedics Antibody Drug Conjugate Products Offered 12.4.5 Immunomedics Recent Development 12.5 Pfizer 12.5.1 Pfizer Corporation Information 12.5.2 Pfizer Business Overview 12.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Pfizer Antibody Drug Conjugate Products Offered 12.5.5 Pfizer Recent Development 12.6 Celldex Therapeutics 12.6.1 Celldex Therapeutics Corporation Information 12.6.2 Celldex Therapeutics Business Overview 12.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Celldex Therapeutics Antibody Drug Conjugate Products Offered 12.6.5 Celldex Therapeutics Recent Development 12.7 Millennium Pharmaceuticals 12.7.1 Millennium Pharmaceuticals Corporation Information 12.7.2 Millennium Pharmaceuticals Business Overview 12.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Millennium Pharmaceuticals Antibody Drug Conjugate Products Offered 12.7.5 Millennium Pharmaceuticals Recent Development 12.8 Bayer HealthCare 12.8.1 Bayer HealthCare Corporation Information 12.8.2 Bayer HealthCare Business Overview 12.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Bayer HealthCare Antibody Drug Conjugate Products Offered 12.8.5 Bayer HealthCare Recent Development 12.9 Mersana Therapeutics 12.9.1 Mersana Therapeutics Corporation Information 12.9.2 Mersana Therapeutics Business Overview 12.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Mersana Therapeutics Antibody Drug Conjugate Products Offered 12.9.5 Mersana Therapeutics Recent Development 12.10 Heidelberg Pharma 12.10.1 Heidelberg Pharma Corporation Information 12.10.2 Heidelberg Pharma Business Overview 12.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Heidelberg Pharma Antibody Drug Conjugate Products Offered 12.10.5 Heidelberg Pharma Recent Development 12.11 Oxford BioTherapeutics 12.11.1 Oxford BioTherapeutics Corporation Information 12.11.2 Oxford BioTherapeutics Business Overview 12.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Oxford BioTherapeutics Antibody Drug Conjugate Products Offered 12.11.5 Oxford BioTherapeutics Recent Development 12.12 Takeda Pharmaceutical Company Limited 12.12.1 Takeda Pharmaceutical Company Limited Corporation Information 12.12.2 Takeda Pharmaceutical Company Limited Business Overview 12.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Products Offered 12.12.5 Takeda Pharmaceutical Company Limited Recent Development 13 Antibody Drug Conjugate Manufacturing Cost Analysis 13.1 Antibody Drug Conjugate Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Antibody Drug Conjugate 13.4 Antibody Drug Conjugate Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Antibody Drug Conjugate Distributors List 14.3 Antibody Drug Conjugate Customers 15 Market Dynamics 15.1 Antibody Drug Conjugate Market Trends 15.2 Antibody Drug Conjugate Drivers 15.3 Antibody Drug Conjugate Market Challenges 15.4 Antibody Drug Conjugate Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Antibody Drug Conjugate Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Antibody Drug Conjugate Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Antibody Drug Conjugate Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Antibody Drug Conjugate Sales (K Units) by Region (2016-2021) Table 5. Global Antibody Drug Conjugate Sales Market Share by Region (2016-2021) Table 6. Global Antibody Drug Conjugate Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Antibody Drug Conjugate Revenue Share by Region (2016-2021) Table 8. Global Antibody Drug Conjugate Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Antibody Drug Conjugate Sales Market Share Forecast by Region (2022-2027) Table 10. Global Antibody Drug Conjugate Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Antibody Drug Conjugate Revenue Share Forecast by Region (2022-2027) Table 12. Global Antibody Drug Conjugate Sales (K Units) of Key Companies (2016-2021) Table 13. Global Antibody Drug Conjugate Sales Share by Company (2016-2021) Table 14. Global Antibody Drug Conjugate Revenue (US$ Million) by Company (2016-2021) Table 15. Global Antibody Drug Conjugate Revenue Share by Company (2016-2021) Table 16. Global Antibody Drug Conjugate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drug Conjugate as of 2020) Table 17. Global Antibody Drug Conjugate Average Price (USD/Unit) of Key Company (2016-2021) Table 18. Manufacturers Antibody Drug Conjugate Manufacturing Sites and Area Served Table 19. Manufacturers Antibody Drug Conjugate Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Antibody Drug Conjugate Sales (K Units) by Type (2016-2021) Table 22. Global Antibody Drug Conjugate Sales Share by Type (2016-2021) Table 23. Global Antibody Drug Conjugate Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Antibody Drug Conjugate Price (USD/Unit) by Type (2016-2021) Table 25. Global Antibody Drug Conjugate Sales Share by Type (2022-2027) Table 26. Global Antibody Drug Conjugate Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Antibody Drug Conjugate Revenue Share by Type (2022-2027) Table 28. Global Antibody Drug Conjugate Price (USD/Unit) by Type (2022-2027) Table 29. Global Antibody Drug Conjugate Sales (K Units) by Application (2016-2021) Table 30. Global Antibody Drug Conjugate Sales Share by Application (2016-2021) Table 31. Global Antibody Drug Conjugate Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Antibody Drug Conjugate Price (USD/Unit) by Application (2016-2021) Table 33. Global Antibody Drug Conjugate Sales (K Units) by Application (2022-2027) Table 34. Global Antibody Drug Conjugate Sales Share by Application (2022-2027) Table 35. Global Antibody Drug Conjugate Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Antibody Drug Conjugate Revenue Share by Application (2022-2027) Table 37. Global Antibody Drug Conjugate Price (USD/Unit) by Application (2022-2027) Table 38. North America Antibody Drug Conjugate Sales (K Units) by Company (2016-2021) Table 39. North America Antibody Drug Conjugate Sales Market Share by Company (2016-2021) Table 40. North America Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Antibody Drug Conjugate Revenue Market Share by Company (2016-2021) Table 42. North America Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units) Table 43. North America Antibody Drug Conjugate Sales Market Share by Type (2016-2021) Table 44. North America Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units) Table 45. North America Antibody Drug Conjugate Sales Market Share by Type (2022-2027) Table 46. North America Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units) Table 47. North America Antibody Drug Conjugate Sales Market Share by Application (2016-2021) Table 48. North America Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units) Table 49. North America Antibody Drug Conjugate Sales Market Share by Application (2022-2027) Table 50. Europe Antibody Drug Conjugate Sales (K Units) by Company (2016-2021) Table 51. Europe Antibody Drug Conjugate Sales Market Share by Company (2016-2021) Table 52. Europe Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Antibody Drug Conjugate Revenue Market Share by Company (2016-2021) Table 54. Europe Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units) Table 55. Europe Antibody Drug Conjugate Sales Market Share by Type (2016-2021) Table 56. Europe Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units) Table 57. Europe Antibody Drug Conjugate Sales Market Share by Type (2022-2027) Table 58. Europe Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units) Table 59. Europe Antibody Drug Conjugate Sales Market Share by Application (2016-2021) Table 60. Europe Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units) Table 61. Europe Antibody Drug Conjugate Sales Market Share by Application (2022-2027) Table 62. China Antibody Drug Conjugate Sales (K Units) by Company (2016-2021) Table 63. China Antibody Drug Conjugate Sales Market Share by Company (2016-2021) Table 64. China Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million) Table 65. China Antibody Drug Conjugate Revenue Market Share by Company (2016-2021) Table 66. China Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units) Table 67. China Antibody Drug Conjugate Sales Market Share by Type (2016-2021) Table 68. China Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units) Table 69. China Antibody Drug Conjugate Sales Market Share by Type (2022-2027) Table 70. China Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units) Table 71. China Antibody Drug Conjugate Sales Market Share by Application (2016-2021) Table 72. China Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units) Table 73. China Antibody Drug Conjugate Sales Market Share by Application (2022-2027) Table 74. Japan Antibody Drug Conjugate Sales (K Units) by Company (2016-2021) Table 75. Japan Antibody Drug Conjugate Sales Market Share by Company (2016-2021) Table 76. Japan Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Antibody Drug Conjugate Revenue Market Share by Company (2016-2021) Table 78. Japan Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units) Table 79. Japan Antibody Drug Conjugate Sales Market Share by Type (2016-2021) Table 80. Japan Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units) Table 81. Japan Antibody Drug Conjugate Sales Market Share by Type (2022-2027) Table 82. Japan Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units) Table 83. Japan Antibody Drug Conjugate Sales Market Share by Application (2016-2021) Table 84. Japan Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units) Table 85. Japan Antibody Drug Conjugate Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Antibody Drug Conjugate Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Antibody Drug Conjugate Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Antibody Drug Conjugate Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Antibody Drug Conjugate Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Antibody Drug Conjugate Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Antibody Drug Conjugate Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Antibody Drug Conjugate Sales Market Share by Application (2022-2027) Table 98. India Antibody Drug Conjugate Sales (K Units) by Company (2016-2021) Table 99. India Antibody Drug Conjugate Sales Market Share by Company (2016-2021) Table 100. India Antibody Drug Conjugate Revenue by Company (2016-2021) & (US$ Million) Table 101. India Antibody Drug Conjugate Revenue Market Share by Company (2016-2021) Table 102. India Antibody Drug Conjugate Sales by Type (2016-2021) & (K Units) Table 103. India Antibody Drug Conjugate Sales Market Share by Type (2016-2021) Table 104. India Antibody Drug Conjugate Sales by Type (2022-2027) & (K Units) Table 105. India Antibody Drug Conjugate Sales Market Share by Type (2022-2027) Table 106. India Antibody Drug Conjugate Sales by Application (2016-2021) & (K Units) Table 107. India Antibody Drug Conjugate Sales Market Share by Application (2016-2021) Table 108. India Antibody Drug Conjugate Sales by Application (2022-2027) & (K Units) Table 109. India Antibody Drug Conjugate Sales Market Share by Application (2022-2027) Table 110. Seattle Genetics/Takeda Corporation Information Table 111. Seattle Genetics/Takeda Description and Business Overview Table 112. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 113. Seattle Genetics/Takeda Antibody Drug Conjugate Product Table 114. Seattle Genetics/Takeda Recent Development Table 115. Roche Corporation Information Table 116. Roche Description and Business Overview Table 117. Roche Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 118. Roche Antibody Drug Conjugate Product Table 119. Roche Recent Development Table 120. ImmunoGen Corporation Information Table 121. ImmunoGen Description and Business Overview Table 122. ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 123. ImmunoGen Antibody Drug Conjugate Product Table 124. ImmunoGen Recent Development Table 125. Immunomedics Corporation Information Table 126. Immunomedics Description and Business Overview Table 127. Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 128. Immunomedics Antibody Drug Conjugate Product Table 129. Immunomedics Recent Development Table 130. Pfizer Corporation Information Table 131. Pfizer Description and Business Overview Table 132. Pfizer Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 133. Pfizer Antibody Drug Conjugate Product Table 134. Pfizer Recent Development Table 135. Celldex Therapeutics Corporation Information Table 136. Celldex Therapeutics Description and Business Overview Table 137. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 138. Celldex Therapeutics Antibody Drug Conjugate Product Table 139. Celldex Therapeutics Recent Development Table 140. Millennium Pharmaceuticals Corporation Information Table 141. Millennium Pharmaceuticals Description and Business Overview Table 142. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 143. Millennium Pharmaceuticals Antibody Drug Conjugate Product Table 144. Millennium Pharmaceuticals Recent Development Table 145. Bayer HealthCare Corporation Information Table 146. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. Bayer HealthCare Description and Business Overview Table 148. Bayer HealthCare Antibody Drug Conjugate Product Table 149. Bayer HealthCare Recent Development Table 150. Mersana Therapeutics Corporation Information Table 151. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. Mersana Therapeutics Description and Business Overview Table 153. Mersana Therapeutics Antibody Drug Conjugate Product Table 154. Mersana Therapeutics Recent Development Table 155. Heidelberg Pharma Corporation Information Table 156. Heidelberg Pharma Description and Business Overview Table 157. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 158. Heidelberg Pharma Antibody Drug Conjugate Product Table 159. Heidelberg Pharma Recent Development Table 160. Oxford BioTherapeutics Corporation Information Table 161. Oxford BioTherapeutics Description and Business Overview Table 162. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 163. Oxford BioTherapeutics Antibody Drug Conjugate Product Table 164. Oxford BioTherapeutics Recent Development Table 165. Takeda Pharmaceutical Company Limited Corporation Information Table 166. Takeda Pharmaceutical Company Limited Description and Business Overview Table 167. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 168. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Table 169. Takeda Pharmaceutical Company Limited Recent Development Table 170. Production Base and Market Concentration Rate of Raw Material Table 171. Key Suppliers of Raw Materials Table 172. Antibody Drug Conjugate Distributors List Table 173. Antibody Drug Conjugate Customers List Table 174. Antibody Drug Conjugate Market Trends Table 175. Antibody Drug Conjugate Market Drivers Table 176. Antibody Drug Conjugate Market Challenges Table 177. Antibody Drug Conjugate Market Restraints Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Antibody Drug Conjugate Product Picture Figure 2. Global Antibody Drug Conjugate Sales Market Share by Type in 2021 & 2027 Figure 3. Adcetris Product Picture Figure 4. Kadcyl Product Picture Figure 5. Other Product Picture Figure 6. Global Antibody Drug Conjugate Sales Market Share by Application in 2021 & 2027 Figure 7. Hospital Examples Figure 8. Pharmaceutical Company Examples Figure 9. Research Institutions Examples Figure 10. Global Antibody Drug Conjugate Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Antibody Drug Conjugate Sales Growth Rate (2016-2027) & (US$ Million) Figure 12. Global Antibody Drug Conjugate Sales (K Units) Growth Rate (2016-2027) Figure 13. Global Antibody Drug Conjugate Price Trends Growth Rate (2016-2027) (USD/Unit) Figure 14. Global Antibody Drug Conjugate Revenue Market Share by Region: 2016 VS 2021 Figure 15. Global Antibody Drug Conjugate Revenue Market Share by Region: 2021 VS 2027 Figure 16. North America Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027) Figure 17. North America Antibody Drug Conjugate Sales (K Units) Growth Rate (2016-2027) Figure 18. Europe Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027) Figure 19. Europe Antibody Drug Conjugate Sales (Million USD) Growth Rate (2016-2027) Figure 20. China Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027) Figure 21. China Antibody Drug Conjugate Sales (Million USD) and Growth Rate (2016-2027) Figure 22. Japan Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027) Figure 23. Japan Antibody Drug Conjugate Sales (Million USD) Growth Rate (2016-2027) Figure 24. Southeast Asia Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027) Figure 25. Southeast Asia Antibody Drug Conjugate Sales (Million USD) Growth Rate (2016-2027) Figure 26. India Antibody Drug Conjugate Revenue (Million USD) Growth Rate (2016-2027) Figure 27. India Antibody Drug Conjugate Sales (Million USD) Growth Rate (2016-2027) Figure 28. Global 5 Largest Antibody Drug Conjugate Players Market Share by Revenue in Antibody Drug Conjugate: 2016 & 2020 Figure 29. Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 30. Global Antibody Drug Conjugate Revenue Share by Type (2016-2021) Figure 31. Global Antibody Drug Conjugate Revenue Growth Rate by Type in 2016 & 2020 Figure 32. Global Antibody Drug Conjugate Revenue Share by Application (2016-2021) Figure 33. Global Antibody Drug Conjugate Revenue Growth Rate by Application in 2016 & 2020 Figure 34. North America Antibody Drug Conjugate Sales Market Share by Type in 2020 Figure 35. North America Antibody Drug Conjugate Sales Market Share by Application in 2020 Figure 36. Europe Antibody Drug Conjugate Sales Market Share by Type in 2020 Figure 37. Europe Antibody Drug Conjugate Sales Market Share by Application in 2020 Figure 38. China Antibody Drug Conjugate Sales Market Share by Type in 2020 Figure 39. China Antibody Drug Conjugate Sales Market Share by Application in 2020 Figure 40. Japan Antibody Drug Conjugate Sales Market Share by Type in 2020 Figure 41. Japan Antibody Drug Conjugate Sales Market Share by Application in 2020 Figure 42. Southeast Asia Antibody Drug Conjugate Sales Market Share by Type in 2020 Figure 43. Southeast Asia Antibody Drug Conjugate Sales Market Share by Application in 2020 Figure 44. India Antibody Drug Conjugate Sales Market Share by Type in 2020 Figure 45. India Antibody Drug Conjugate Sales Market Share by Application in 2020 Figure 46. Key Raw Materials Price Trend Figure 47. Manufacturing Cost Structure of Antibody Drug Conjugate Figure 48. Manufacturing Process Analysis of Antibody Drug Conjugate Figure 49. Antibody Drug Conjugate Industrial Chain Analysis Figure 50. Channels of Distribution Figure 51. Distributors Profiles Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Seattle Genetics/Takeda Roche ImmunoGen Immunomedics Pfizer Celldex Therapeutics Millennium Pharmaceuticals Bayer HealthCare Mersana Therapeutics Heidelberg Pharma Oxford BioTherapeutics Takeda Pharmaceutical Company Limited